AptarGroup, Inc. (ATR) Stock AnalysisATRAptarGroup, Inc.

AptarGroup, Inc. is engaged in the design and manufacturing of drug and consumer product dosing, dispensing, and protection technologies. The Company serves diversified end markets including pharmaceutical, fragrance, facial skincare, color cosmetics, food, beverage, personal care, and home care. It also manufactures and sells elastomeric primary packaging components. It operates through three segments, which include the Pharma segment, Beauty segment, and Closures segment. The Pharma segment is a supplier of nasal drug delivery spray pumps and metered dose inhaler valves (MDIs) to the pharmaceutical and health care markets worldwide. The Beauty segment sells pumps, airless systems and valves to the fragrance, color cosmetics, facial skincare, personal care, and home care markets. The Closures segment includes dispensing and non-dispensing solutions that enable product delivery without removal of the cap and are used across multiple consumer end markets. It operates in the Basic Materials sector (PLASTICS PRODUCTS, NEC industry).

Aptargroup Inc is currently priced at $120.38, which is below the average analyst price target of $150, indicating potential upside. However, the stock has an RSI of 37.32, suggesting it is oversold, but the recent performance shows a 1-year decline of 7.56%, indicating ongoing challenges. The main risk is the company's declining gross margin, which fell to 27.85% in Q2 2026, down from 30.89% in Q4 2024, reflecting pressures on profitability.

9 analysts cover ATR: 2 rate it Buy, 6 Hold and 1 Sell. The average price target is 145.33.